ABSTRACT
INTRODUCTION
Masticatory myalgia (MM) is deep somatic pain, characterized by fatigue or pain worsened by jaw passive or functional movement, which may limit mouth opening 1 . There is controversy about the most adequate therapeutic approach to control MM. Recommendations include a wide variety of procedures including rest, thermal therapy, stretching, exercises, massage, acupressure, intervention on tri-ORIGINAL ARTICLE DOI 10.5935/1806-0013.20150032 gger-points (TP), behavioral therapy, occlusal splints, drugs and placebo 2 . Pharmacological therapies, such as muscle relaxants and antidepressants, have been widely applied to control such myalgias 3 , however they have adverse effects. There is currently increasing interest on neuromodulating therapies, such as acupuncture and electric therapy modalities, such as percutaneous electric nerve stimulation (PENS). Acupuncture is part of integrative and complementary treatment practices recognized by the World Health Organization (WHO). This therapy has been used to control different types of pain, with a safety pattern that makes it adequate for clinical practice 4 . Recent advances in the establishment of control groups for acupuncture have allowed the design of more reliable studies 5 . Acupuncture improves signs and symptoms associated to temporomandibular disorders 6 , and increases pain tolerance threshold of the masseter muscle 7 . PENS is considered a new electroanalgesia modality, with the therapeutic advantages of transcutaneous electric nerve stimulation (TENS) and of electroacupuncture 8, 9 . It consists in inserting acupuncture needles associated to bipolar electric conduits in the region of the dermatome corresponding to the source of pain 9, 10 . PENS is effective to control pain in the short 11 and long term, with possible cumulative analgesic effect during application sessions 12 . This study aimed at comparing the analgesic effect of PENS on MM.
METHODS
The study was developed in the Orofacial Pain Control Center, School of Dentistry, University of Pernambuco, according to principles of Resolution 466/2012 of the National Health Council, Department of Health, and in compliance with the Declaration of Helsinki. Population was made up of spontaneous or referred demand, aged between 22 and 64 years, with MM. Participation was made effective by free and sovereign will through the reading and signing of the Free and Informed Consent Term (FICT). Inclusion criteria were pain for more than three months, of muscular origin and unilaterally or bilaterally affecting the masseter muscle; ability to read, understand and cooperate with the clinical evaluation of the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) and visual analog scale (VAS). Exclusion criteria were patients with intra-articular disorders; history of facial trauma; reported pain of high intensity suggesting the need for pharmacological control; pregnancy, epilepsy or cardiac pace-maker; history of malignant tumors; orofacial tissue infection; presence of dysesthesia at intervention site; totally edentulous without oral rehabilitation. In a first screening we have selected among orofacial pain (OFP) patients those with symptoms related to temporomandibular disorders (TMD) for more than three months, using the Simplified Anamnesis Questionnaire 13 . Then, those meeting inclusion criteria were examined by an investigator qualified to apply RDC/TMD and blind to the experiment 14 , being selected MM patients. Groups were randomized to acupuncture group (AG) (n=12) and PENS group (PG) (n=11).
INTERVENTION
Patients of both groups were asked to discontinue any symptoms-controlling drug two days before the experiment 15 . For both groups, treatment consisted of two weekly sessions, for five weeks, lasting 20 minutes each, counted as from selected points stimulation, in a total of 9 sessions. Any type of communication different from intervention-related issues was avoided between investigator and patient. For AG, intervention protocol was developed as from literature reviews and clinical experience 16, 17 by a dentist qualified in acupuncture by the Federal Council of Dentistry with seven years of experience. Selected points were IG4, E36, F3 and Shem Men (bilateral auricular), VG20 and Yintang, all systemic points and far from the pain site, in an attempt to avoid dry TP needling of the masseter muscle. Those points were chosen due to their action on chronic pain control and symptoms commonly associated to TMD, such as anxiety, emotional stress and depression. Application sites were previously cleaned with 70% alcohol and disposable needles (0.25x30 mm) were inserted at 10 to 20mm depth. In all patients needles were initially stimulated to reach "De Qi" and remained inserted without stimulation until the end of the session. For PG, a different investigator has selected the areas of electric stimulation application according to painful points, identified by manual palpation with approximately 1 kmf/ cm 2 digital pressure. Before the procedure, all patients were submitted to proprioception test which, if negative, would impair the adjustment of electric stimulation intensity for PENS, in addition to masking digital pressure inspection result 18 . The device was DIAN-E, NKL brand, gauged by the Institute São Paulo. Protocol consisted in the introduction of two acupuncture needles (0.20x13mm) perpendicular to the muscle, and a needle inserted in the painful point and the other 1cm of it, with depth of 10 to 13mm compatible with the volume of the involved muscle and with adequate stabilization of each needle. Electric stimulation parameter was pulse frequency of 100Hz, continuous pulse pattern and bidirectional symmetric rectangular pulse shape. Current intensity was tailored according to the tolerance of each patient 19 , being increased to produce the most intense and tolerable electric sensation. Participants of both groups would describe pain intensity by means of 10-cm VAS, without numbers and with the words no pain and worst imaginable pain on both ends, by means of the question: "What is the pain felt right now?" Answers were measured by an investigator blind to treatment sessions. Due to the possibility of symptoms due to needling interventions, it was established that measurements would be carried out before the first session and immediately before the fifth and ninth (last) interventions. So, for data collection purposes, we have totaled evaluation and results related to eight treatment sessions, because in the ninth application session pain intensity was measured only before the procedure.
Statistical analysis
Data analysis has generated absolute distribution of mean statistical measurements and standard deviation (descriptive statistics), and the following statistical tests were used: Student t with equal variances and F test (ANOVA) to check equality of variances between groups, with Bonferroni correction (inferential statistics) among measurements. Statistical calculations were made with the program Statistical Package for the Social Sciences, version 15, and error margin for statistical tests decision was 5.0%. This study was approved by the Ethics Committee, University of Pernambuco under n. 080/2007.
RESULTS
From 190 patients initially evaluated with OFP, 103 had TMD and in 52 the masseter muscle was unilaterally or bilaterally involved. From these, 23 were randomized in two groups, AG=12 and PG=11 (Figure 1 ). One GP patient and two AG patients were lost due to abandonment and report of VAS=10, both during the experiment. Age mean and standard deviation for AG was 40.60 and 14.26 years, respectively, and for PG it was 37.10 and 8.17 years. Table 1 shows socio-demographic data of the studied population. Mean VAS values used for pain measurement are shown in table 2. Taking as reference the first measurement, where mean values are statistically similar by Student t test, there has been significant mean VAS decrease in further measurements for both groups by the F test (ANOVA). By means of Bonferroni correction, these differences were located between the first and the second and between the first and the third measurements.
There has been no statistically significant difference in the last measurement in mean VAS value between AG and PG (Student t test). There has been no relevant intervention-related adverse effect in both groups. Two AG patients have referred mild sedation during intervention.
DISCUSSION
Neuromodulating therapies seem to have satisfactory results to relief musculoskeletal pain [5] [6] [7] 10, 16, 17 . In our study, results have shown decrease of symptoms intensity in groups AG and PG, being that AG patients had mean values statistically lower than PG in the last measurement. It has been suggested that PENS has a cumulative effect during treatment, perceived by the maintenance of the analgesic effect at each intervention 12 . This fact may be considered in the results of our study, translated into decreased VAS at each measurement in the first, third and last treatment weeks. Although PENS being considered a new therapeutic modality 9 , it does not seem to differ, in practice and principles, from electroacupuncture 19 , except with regard to application points. In our study, sites to place needles in PG were points corresponding to the source of pain reported by patients and confirmed by physical evaluation. For AG, chosen puncture points were systemic acupuncture points located distant from the pain site. It has been shown that acupuncture points often coincide with common symptomatic regions of masticatory muscles. Point E7, for example, corresponds to the location of a latent TG in the masseter region, reported by several individuals with facial pain. So, one should not discard the possibility that part of pain relief in PG could be effect of the simple puncture of acupuncture points in the muscle, and not of the electric stimulation. Both techniques were effective to control short term pain in AG and PG 7, 11 Acupuncture had differentiated results when compared to placebo without needle insertion, suggesting clinically significant neuromodulating mechanisms as consequence of the puncture 17 . This neuromodulating therapy was effective, in the short term, to decrease TMD-related pain of muscular origin 16 , confirming the results of this study. The difficulty to select patients exclusively with masseter muscle MM has determined a small sample. Future studies with larger samples may consistently confirm our results.
